Phase I study of intravenous (IV) milataxel in adult patients with advanced malignant tumors.

被引：0
|
作者：
Bourbouloux, E.
Campone, M.
Vermorken, J. B.
Martin, M.
Sessa, C.
Perotti, A.
机构：
[1] Univ Antwerp Hosp, Antwerp, Belgium
[2] Hosp Clin Univ San Carlos, Madrid, Spain
[3] Osped San Giovani, Bellinzona, Switzerland
[4] Ist Nazl Tumori, I-20133 Milan, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：88S / 88S
页数：1
相关论文
共 50 条
  • [41] A phase I trial of the combination of erlotinib and tipifarnib in patients with advanced solid tumors.
    Ma, CX
    Croghan, G
    Reid, J
    Hanson, L
    Mandrekar, S
    Marks, R
    Adjei, A
    Furth, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 192S - 192S
  • [42] Results of phase I clinical trials of Coramsine in patients with advanced solid tumors.
    Millward, M.
    Powell, A.
    Daly, P.
    Tyson, S.
    Ferguson, R.
    Carter, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 96S - 96S
  • [43] Gemcitabine and Docetaxel in patients with advanced solid tumors. A GETICS phase I trial
    Jaremtchuk, AV
    Zabra, JJ
    Ferro, A
    Aman, EF
    Alvarez, R
    Arroyo, G
    Marmissolle, F
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S290 - S290
  • [44] Phase I trial of cabazitaxel plus cisplatin in patients with advanced solid tumors.
    Lockhart, Albert C.
    Sundaram, Shankar
    Sarantopoulos, John
    Mita, Monica M.
    Lane, Alex R.
    Moseley, Jennifer L.
    Dedieu, Jean-Francois
    Stash, Diane
    Zhi, Xin
    Mazuir, Florent
    Mita, Alain C.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [45] A phase I study of intravenous fenretinide (4-HPR) for patients with malignant solid tumors
    Jacob S. Thomas
    Anthony B. El-Khoueiry
    Barry J. Maurer
    Susan Groshen
    Jacek K. Pinski
    Everardo Cobos
    David R. Gandara
    Heinz J. Lenz
    Min H. Kang
    C. Patrick Reynolds
    Edward M. Newman
    Cancer Chemotherapy and Pharmacology, 2021, 87 : 525 - 532
  • [46] A phase I study of intravenous fenretinide (4-HPR) for patients with malignant solid tumors
    Thomas, Jacob S.
    El-Khoueiry, Anthony B.
    Maurer, Barry J.
    Groshen, Susan
    Pinski, Jacek K.
    Cobos, Everardo
    Gandara, David R.
    Lenz, Heinz J.
    Kang, Min H.
    Reynolds, C. Patrick
    Newman, Edward M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 87 (04) : 525 - 532
  • [47] A phase I dose-escalation and immune biomarker study of intravenous FF-10832, liposomal gemcitabine, in patients with advanced solid tumors.
    Borazanci, Erkut Hasan
    Falchook, Gerald Steven
    Abbas, Atif
    Wheeler, Catherine A.
    Maier, Gary
    Johansen, Mary
    Sedivy, Paula
    Subach, Ruth Ann
    Sen, Shiraj
    Jones, Suzanne Fields
    Ioroi, Tadaaki
    Matsumoto, Takeshi
    Suzuki, Takeaki
    Madden, Timothy
    Hamilton, Erika Paige
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [48] A phase 1 study of oral navelbine in patients with advanced solid tumors.
    Rajdev, L
    Dai, Q
    Mani, S
    Goldberg, G
    Baker, C
    Hoschander, S
    Sparano, J
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6137S - 6137S
  • [49] A phase II study of temozolomide and bevacizumab in patients with advanced neuroendocrine tumors.
    Kulke, M. H.
    Stuart, K.
    Earle, C. C.
    Bhargava, P.
    Clark, J. W.
    Enzinger, P. C.
    Meyerhardt, J.
    Attawia, M.
    Lawrence, C.
    Fuchs, C. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 189S - 189S
  • [50] Phase I study of weekly docetaxel and topotecan in the treatment of advanced solid tumors.
    Tan, BR
    Read, W
    Bergeron, K
    Fracasso, PM
    Govindan, R
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 702S - 702S
12345